Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
10 Years of Leadership Lessons

Oct 11, 2022/Article

For the past decade, aspiring and developing directors of PT and PTA education programs have been gaining the skills they need to be influential and visionary leaders thanks to an award-winning APTA program. So far, 165 graduates have completed the program and the 2022-23 class is the largest-ever, with

Study: 54% of Middle-Income Seniors Won't be Able to Afford Assisted Living Costs, Medical Expenses in 10 Years

May 1, 2019/Review

As the wave of aging baby boomers advances, the middle-income elderly population could find itself struggling.

Keeping Pain Out of the Red Zone

Jul 1, 2017/Feature

The mechanisms of pain are both physical and psychological. Here's what PTs and PTAs need to know in order to gauge treatment strategies.

A Different Kind of Group Therapy

Feb 1, 2016/Column

Identifying and addressing a chronic need.

Transformation Requires Reinvention

Mar 1, 2017/Perspective

Employers may be the ideal starting point as they have a direct interest in lowering health care costs.

New APTA Strategic Plan: Leading the Profession and Association Into the Next Century

Jan 28, 2019/News

Take a look at the new APTA strategic plan covering the next 3 years, and almost immediately something becomes abundantly clear: the association has no intention of kicking back and cruising into its centennial in 2021. Dig deeper, and you're likely to find that the goals to be reached between now and

CDC: Fall-Related TBI Death Jumped 17% 2008-2017

Mar 13, 2020/Review

The rate of deaths related to traumatic brain injury received in a fall has climbed 17% in 10 years.

APTA Glenohumeral Joint OA Clinical Practice Guideline Now Available

May 12, 2023/Review

The new resource, designed specifically for PTs and PTAs, includes evidence-based and best-practice recommendations.

10-Meter Walk Test (10MWT) for Cerebral Palsy (CP)

Jan 15, 2015/Test & Measure

Target population: Children with neuromuscular disease, including cerebral palsy (CP).